• Home | Global Data CRO
  • Our Company
    • About Us
    • Executive Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Global Leaders
    • Working with MMS
    • Certifications
  • Services
    • Regulatory Affairs
      • Regulatory Affairs Services
      • Regulatory Strategy Consulting
      • Regulatory Affairs Management
      • Regulatory Operations
    • Data Management and Biostatistics
    • Regulatory and Medical Writing
    • Transparency Services
      • Transparency and Disclosure Services
      • REGISTRATION AND RESULTS DISCLOSURES
      • Data and Document Anonymization
      • LAY SUMMARIES
    • Quality and Compliance services
    • Drug Safety and Pharmacovigilance
    • Rare Disease
    • Quality Control Services
    • Project Advisory Services
    • Data Science
  • Technology
    • Automatiqc
    • Datacise
    • PVantage
    • Technology Implementation
    • SmartStart Document Templates
  • Functional Services (FSP)
  • Webinars
  • News and Media
  • MMS Blog
  • Careers
    • MMS Careers
    • Opportunities
    • MMS Experience
    • MMS Culture
    • Global Benefits
    • FAQ
  • Learning
  • Contact Us
MMS Holdings
MMS Poised for an Innovative Future with Best Clinical Research Organization Award and Two Key Executive Appointments

MMS Poised for an Innovative Future with Best Clinical Research Organization Award and Two Key Executive Appointments

by Avery Zimmerman | Jul 21, 2021 | News

CANTON, Mich. (July 21, 2021) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced the growth of its leadership team with the appointment of Kelly J. Hill to Executive Vice President (EVP) of Global Business Operations and Strategy and...

Recent Posts

  • A Step-by-Step Approach to Determining Company Confidential Information (CCI) in Redaction Proposal Packages
  • Exploring the use of Real-World Evidence in Regulatory Decision Making Under PDUFA VII
  • Updates to FDA Meetings under PDUFA VII
  • Drug Safety Updates: What’s New Under PDUFA VII?
  • CMC and Quality Enhancements Under PDUFA VII Explained

Tags

Alzheimers biostatistician biostatistics clinical research clinical study reports clinical trial disclosure clinical trials clinical trial transparency Compliance conference COVID-19 CRO data management data privacy data science decentralized clinical trials drug development eCOA & ePro EMA FDA FSP GXP auditing Health Analytics Collective IND submission innovation Lay summaries leadership machine learning medical writing MMS Academy NDA submission Orphan Drug Designation Applications pharmacovigilance PhUSE plain language summary quality and compliance quality control real world data regulatory affairs regulatory operations regulatory quality control REMS statistical programming transparency Volunteering